Voloridge Investment Management
HIMS icon

Voloridge Investment Management’s Hims & Hers Health HIMS Stock Holding History

Voloridge Investment Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,479,294
Closed -$27.2M – 1260
2024
Q3 		$27.2M Sell
1,479,294
-301,608
-17% -$5.4M 0.1% 298
2024
Q2 		$36M Sell
1,780,902
-1,264,271
-42% -$21M 0.13% 223
2024
Q1 		$47.1M Buy
3,045,173
+2,447,021
+409% +$27.6M 0.17% 170
2023
Q4 		$5.32M Sell
598,152
-995,725
-62% -$7.36M 0.02% 605
2023
Q3 		$10M Sell
1,593,877
-5,447
-0.3% -$40.5K 0.05% 462
2023
Q2 		$15M Buy
1,599,324
+385,501
+32% +$3.82M 0.07% 360
2023
Q1 		$12M Buy
1,213,823
+978,633
+416% +$8.58M 0.06% 405
2022
Q4 		$1.51M Sell
235,190
-103,075
-30% -$587K 0.01% 1041
2022
Q3 		$1.89M Buy
338,265
+300,463
+795% +$1.81M 0.01% 999
2022
Q2 		$171K Sell
37,802
-107,771
-74% -$460K ﹤0.01% 1385
2022
Q1 		$776K Sell
145,573
-32,080
-18% -$159K ﹤0.01% 1179
2021
Q4 		$1.16M Sell
177,653
-339,728
-66% -$2.46M 0.01% 1234
2021
Q3 		$3.9M Buy
+517,381
New +$4.38M 0.03% 780

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Voloridge Investment Management's HIMS Position: Q4 2024 in Review

Voloridge Investment Management sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 1,479,294 shares — an estimated $27.2M sold.

Voloridge Investment Management first reported a position in HIMS in Q3 2021 and held it in 13 quarters. The position peaked at $47.1M in Q1 2024. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

  • Voloridge Investment Management reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 1,479,294 Hims & Hers Health shares in Q4 2024, an estimated $27.2M.
  • Voloridge Investment Management first reported a position in Hims & Hers Health in Q3 2021 and held it in 13 quarters.
  • Voloridge Investment Management's Hims & Hers Health position peaked at $47.1M in Q1 2024.
  • 394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.